" Once primarily a support function of Sales & Marketing, Medical Affairs is becoming the central player in establishing and maintaining a drug's value in the market. "

Medical Affairs is becoming the central player in establishing and maintaining a drug's value in the market: regulators are giving more fast-track approvals to drugs as they push for faster patient access to innovations. As a consequence, parts of drug development are shifted into the market, where Medical Affairs is the critical player in helping a drug reach its target product profile (TPP) and full potential. Moreover, today, a product must continuously demonstrate its medical benefits as well as its health economic value proposition in the local context.
To win in the future, Medical Affairs will have to play a more active and central role. But, there is no one-size-fits-all solution. To see where to start, download our whitepaper on Medical Affairs. If you like to discuss what this means for your company, reach out to our Roland Berger experts!
New roles of Medical Affairs in the “new world”: To win in the future, Medical Affairs will have to play a more active and central role.